Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Atomic Alchemy
Idaho Falls, Idaho, United States
- Ownership
- Private
- Employees
- ~8
- Development stage
- Other
01
Overview
Atomic Alchemy, as part of Oklo, is building the first scalable commercial production facility for radioisotopes in the U.S. using proprietary small modular reactors, aiming to address shortages in medical imaging and cancer therapy isotopes; no clinical trial results are provided as Atomic Alchemy is a supply chain and platform company, not a drug developer[1][2][3][4][5][6].
- Therapeutic areas
- OncologyOther
- Modalities
- RadiopharmaceuticalRadioisotope
- Industry
- Chemicals & Materials
02
Partnerships
Oklo
Beyond the preview
Go deeper on Atomic Alchemy.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Atomic Alchemy.